2.1.2015
•
News
KŠB’s Karlovy Vary Branch Has Moved
As of 1 December 2015, KŠB’s Karlovy Vary branch is in a new location: Závodní 391/96C, 36006 Karlovy Vary
KŠB’s new office is located in a business park which was redeveloped from former barracks at the beginning of 2000. Other occupants include the regional government, the regional office of the Regional Council of the North-Western Cohesion Region, an eye clinic, and a restaurant. By the summer of 2015, the entire business park is scheduled to undergo major architectural redevelopment under the leadership of top Czech architect Bára Škorpilová.
“I believe the new premises offer greater comfort and convenience for our clients and will contribute to improving the quality of the legal services we offer”, said Dagmar Dubecká, KŠB’s managing partner.
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
